September 30, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for OraRisk, a saline oral rinse COVID-19 test from OralDNA Labs. OraRisk is a reverse transcription polymerase chain reaction (RT-PCR) test that is the first saline 30-second swish and gargle collection COVID-19 test to get an EUA.
The EUA gives OralDNA the authority to use the test specifically for the detection of nucleic acid from SARS-CoV-2.
OraRisk eliminates the need for a nasal swab and avoids the difficulty some people encounter in providing an adequate amount of saliva for direct SARS-CoV-2 testing. Samples are viable for up to 72 hours and do not require cold pack transportation.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current